Literature DB >> 19140239

Impact of p27mt gene on transplantation model of human colorectal cancer in nude mice.

Jun Chen1, Wu Hua Ding, Guang Xin Lu, Shao Yong Xu.   

Abstract

AIM: To investigate the inhibitory and anti-metastatic effect of mutant p27 gene (p27mt) on the growth of colorectal cancer xenografts in nude mice and its underlying mechanism.
METHODS: Inhibitory effect of p27mt gene on the growth of colorectal cancer xenografts was determined by measurement of tumor size before and after direct intra-tumoral injection of Ad-p27mt in a pre-established transplantation model of human colorectal cancer in nude mice. Cell cycle and apoptosis were detected by flow cytometry performed on single-cell suspension from an isolated tumor. Expression of MMP-9 in tumor tissue was detected by immunohistochemistry.
RESULTS: The average sizes of transplantation tumors were 1.94 +/- 0.67 cm(3), 2.75 +/- 0.83 cm(3) and 3.01 +/- 0.76 cm(3) in the Ad-p27mt, Ad-LacZ and control groups, respectively (P < 0.05). The average proliferation rates were 37.34% +/- 1.45%, 53.16% +/- 3.27% and 54.48% +/- 2.43%, in the Ad-p27mt, Ad-LacZ and control groups, respectively (P < 0.05). The average apoptosis rates were 19.79% +/- 3.32%, 6.38% +/- 4.91% and 7.25% +/- 5.20% in the Ad-p27mt, Ad-LacZ and control groups, respectively (P < 0.01). The average MMP-9 expression rates were 20%, 75% and 66.7% in the Ad-p27mt, Ad-LacZ and control groups, respectively (P < 0.01).
CONCLUSION: p27mt inhibits the growth of transplanted tumor by blocking the proliferation of cancer xenografts and by promoting apoptosis of transplantated tumor cells, as well as decrease transpl-anted tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140239      PMCID: PMC2653333          DOI: 10.3748/wjg.15.369

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Overexpression of a stabilized mutant form of the cyclin-dependent kinase inhibitor p27(Kip1) inhibits cell growth.

Authors:  Jean A Hurteau; Susan A Brutkiewicz; Qi Wang; Bernadette M Allison; Mark G Goebl; Maureen A Harrington
Journal:  Gynecol Oncol       Date:  2002-07       Impact factor: 5.482

2.  Immunohistochemical characterization of cyclin E and p27KIP1 expression in early hydatidiform moles.

Authors:  Masaharu Fukunaga
Journal:  Int J Gynecol Pathol       Date:  2004-07       Impact factor: 2.762

3.  The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.

Authors:  D Ganoth; G Bornstein; T K Ko; B Larsen; M Tyers; M Pagano; A Hershko
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

4.  An adenovirus expressing mutant p27 showed more potent antitumor effects than adenovirus-p27 wild type.

Authors:  K H Park; J Y Seol; T Y Kim; C G Yoo; Y W Kim; S K Han; Y S Shim; C T Lee
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

5.  Effects of ischemic preconditioning on cyclinD1 expression during early ischemic reperfusion in rats.

Authors:  Fang-Gang Cai; Jian-Sheng Xiao; Qi-Fa Ye
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

6.  Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.

Authors:  Ke-Jun Nan; Zhao Jing; Ling Gong
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

7.  p27Kip1 is expressed in proliferating cells in its form phosphorylated on threonine 187.

Authors:  Giancarlo Troncone; Juan C Martinez; Antonino Iaccarino; Pio Zeppa; Alessia Caleo; Maria Russo; Ilenia Migliaccio; Maria L Motti; Daniela Califano; Emiliano A Palmieri; Lucio Palombini
Journal:  BMC Clin Pathol       Date:  2005-02-23
  7 in total
  1 in total

1.  The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells.

Authors:  Y X Guo; Y H Xu; G H Zheng; X Q Jin
Journal:  Cancer Gene Ther       Date:  2017-07-21       Impact factor: 5.987

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.